Could Increasing the Duration of Triple Therapy Be a Clinically Useful Strategy?
- Xavier Calvet, MD, PhD;
- Albert Villoria, MD; and
- Mercedes Vergara, MD, PhD
- From Hospital de Sabadell, CIBERehd Instituto de Salud Carlos III, Sabadell 08208, Spain.
TO THE EDITOR:
We would like to congratulate Fuccio and colleagues (1) on their well-performed meta-analysis comparing different durations of triple therapy for Helicobacter pylori infection. However, we disagree with their conclusion that prolonging treatment is unlikely to be a clinically useful strategy. In our opinion, this statement is not supported by their results. The authors confirm previous findings (2, 3) that extending duration of treatment from 7 days to 10 or 14 days improves eradication rates, although the improvements in eradication rates (4% …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
